Report Detail
Global (United States, European Union and China) Anti-Inflammatory Peptides Market Research Report 2019-2025
- RnM3578828 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal\'s skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. Anti-Inflammatory peptides are used to treat diseases such as psoriasis, multiple sclerosis, inflammatory bowel disease and other autoimmune diseases.
North America has dominated the entire market in 2014, as it has presence of technologically updated systems, strong research & development, and high patient awareness levels in this region. Latin America is also expected to grow at a healthy rate as a result of increase in both private and public associations, causing an increase in the investment, thereby boosting the demand for the anti-inflammatory peptides. However, the Asia Pacific region is expected to witness lucrative growth during the forecast period owing to the rapidly improving healthcare infrastructure in the growing economies of India and China. Growing patient awareness levels among the population of this region coupled with high unmet needs of the patients is expected to further drive this region.
In 2019, the market size of Anti-Inflammatory Peptides is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Inflammatory Peptides.
This report studies the global market size of Anti-Inflammatory Peptides, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Inflammatory Peptides sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Mylan Pharmaceuticals
Novartis AG
Rogne Bioscience
Merck Serono
F4 Pharma
Araim Pharmaceuticals, Inc.
Digna Biotech
Abbvie Corporation
Market Segment by Product Type
Cardiovascular Diseases
Gastrointestinal Diseases
Dermatological Diseases
Neurological Diseases
Otorhino Diseases & Ophthalmological
Respiratory Diseases & Pulmonary
Renal Diseases
Rheumatological & Autoimmune Diseases
Transplantation
Market Segment by Application
Hospital Use
Clinic Use
Household
Other
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti-Inflammatory Peptides status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Inflammatory Peptides manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti-Inflammatory Peptides are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anti-Inflammatory Peptides Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Cardiovascular Diseases
- 1.3.3 Gastrointestinal Diseases
- 1.3.4 Dermatological Diseases
- 1.3.5 Neurological Diseases
- 1.3.6 Otorhino Diseases & Ophthalmological
- 1.3.7 Respiratory Diseases & Pulmonary
- 1.3.8 Renal Diseases
- 1.3.9 Rheumatological & Autoimmune Diseases
- 1.3.10 Transplantation
- 1.4 Market Segment by Application
- 1.4.1 Global Anti-Inflammatory Peptides Market Share by Application (2019-2025)
- 1.4.2 Hospital Use
- 1.4.3 Clinic Use
- 1.4.4 Household
- 1.4.5 Other
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anti-Inflammatory Peptides Market Size
- 2.1.1 Global Anti-Inflammatory Peptides Revenue 2014-2025
- 2.1.2 Global Anti-Inflammatory Peptides Sales 2014-2025
- 2.2 Anti-Inflammatory Peptides Growth Rate by Regions
- 2.2.1 Global Anti-Inflammatory Peptides Sales by Regions 2014-2019
- 2.2.2 Global Anti-Inflammatory Peptides Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anti-Inflammatory Peptides Sales by Manufacturers
- 3.1.1 Anti-Inflammatory Peptides Sales by Manufacturers 2014-2019
- 3.1.2 Anti-Inflammatory Peptides Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anti-Inflammatory Peptides Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti-Inflammatory Peptides Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anti-Inflammatory Peptides Market Concentration Ratio (CR5 and HHI)
- 3.3 Anti-Inflammatory Peptides Price by Manufacturers
- 3.4 Key Manufacturers Anti-Inflammatory Peptides Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anti-Inflammatory Peptides Market
- 3.6 Key Manufacturers Anti-Inflammatory Peptides Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Cardiovascular Diseases Sales and Revenue (2014-2019)
- 4.1.2 Gastrointestinal Diseases Sales and Revenue (2014-2019)
- 4.1.3 Dermatological Diseases Sales and Revenue (2014-2019)
- 4.1.4 Neurological Diseases Sales and Revenue (2014-2019)
- 4.1.5 Otorhino Diseases & Ophthalmological Sales and Revenue (2014-2019)
- 4.1.6 Respiratory Diseases & Pulmonary Sales and Revenue (2014-2019)
- 4.1.7 Renal Diseases Sales and Revenue (2014-2019)
- 4.1.8 Rheumatological & Autoimmune Diseases Sales and Revenue (2014-2019)
- 4.1.9 Transplantation Sales and Revenue (2014-2019)
- 4.2 Global Anti-Inflammatory Peptides Sales Market Share by Type
- 4.3 Global Anti-Inflammatory Peptides Revenue Market Share by Type
- 4.4 Anti-Inflammatory Peptides Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anti-Inflammatory Peptides Sales by Application
6 United States
- 6.1 United States Anti-Inflammatory Peptides Breakdown Data by Company
- 6.2 United States Anti-Inflammatory Peptides Breakdown Data by Type
- 6.3 United States Anti-Inflammatory Peptides Breakdown Data by Application
7 European Union
- 7.1 European Union Anti-Inflammatory Peptides Breakdown Data by Company
- 7.2 European Union Anti-Inflammatory Peptides Breakdown Data by Type
- 7.3 European Union Anti-Inflammatory Peptides Breakdown Data by Application
8 China
- 8.1 China Anti-Inflammatory Peptides Breakdown Data by Company
- 8.2 China Anti-Inflammatory Peptides Breakdown Data by Type
- 8.3 China Anti-Inflammatory Peptides Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anti-Inflammatory Peptides Breakdown Data by Company
- 9.2 Rest of World Anti-Inflammatory Peptides Breakdown Data by Type
- 9.3 Rest of World Anti-Inflammatory Peptides Breakdown Data by Application
- 9.4 Rest of World Anti-Inflammatory Peptides Breakdown Data by Countries
- 9.4.1 Rest of World Anti-Inflammatory Peptides Sales by Countries
- 9.4.2 Rest of World Anti-Inflammatory Peptides Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Mylan Pharmaceuticals
- 10.1.1 Mylan Pharmaceuticals Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.1.4 Anti-Inflammatory Peptides Product Introduction
- 10.1.5 Mylan Pharmaceuticals Recent Development
- 10.2 Novartis AG
- 10.2.1 Novartis AG Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.2.4 Anti-Inflammatory Peptides Product Introduction
- 10.2.5 Novartis AG Recent Development
- 10.3 Rogne Bioscience
- 10.3.1 Rogne Bioscience Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.3.4 Anti-Inflammatory Peptides Product Introduction
- 10.3.5 Rogne Bioscience Recent Development
- 10.4 Merck Serono
- 10.4.1 Merck Serono Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.4.4 Anti-Inflammatory Peptides Product Introduction
- 10.4.5 Merck Serono Recent Development
- 10.5 F4 Pharma
- 10.5.1 F4 Pharma Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.5.4 Anti-Inflammatory Peptides Product Introduction
- 10.5.5 F4 Pharma Recent Development
- 10.6 Araim Pharmaceuticals, Inc.
- 10.6.1 Araim Pharmaceuticals, Inc. Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.6.4 Anti-Inflammatory Peptides Product Introduction
- 10.6.5 Araim Pharmaceuticals, Inc. Recent Development
- 10.7 Digna Biotech
- 10.7.1 Digna Biotech Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.7.4 Anti-Inflammatory Peptides Product Introduction
- 10.7.5 Digna Biotech Recent Development
- 10.8 Abbvie Corporation
- 10.8.1 Abbvie Corporation Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Anti-Inflammatory Peptides
- 10.8.4 Anti-Inflammatory Peptides Product Introduction
- 10.8.5 Abbvie Corporation Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anti-Inflammatory Peptides Sales Channels
- 11.2.2 Anti-Inflammatory Peptides Distributors
- 11.3 Anti-Inflammatory Peptides Customers
12 Market Forecast
- 12.1 Global Anti-Inflammatory Peptides Sales and Revenue Forecast 2019-2025
- 12.2 Global Anti-Inflammatory Peptides Sales Forecast by Type
- 12.3 Global Anti-Inflammatory Peptides Sales Forecast by Application
- 12.4 Anti-Inflammatory Peptides Forecast by Regions
- 12.4.1 Global Anti-Inflammatory Peptides Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anti-Inflammatory Peptides Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Inflammatory Peptides. Industry analysis & Market Report on Anti-Inflammatory Peptides is a syndicated market report, published as Global (United States, European Union and China) Anti-Inflammatory Peptides Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti-Inflammatory Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
